Join Nasal-Phyto Company News Technical Support 中文

Join Nasal-Phyto Company News Technical Support Chinese

Categories Of News

New drugs that benefit 340 million patients worldwide are expected to be declared for listing next y

Author:adminTime:2019/12/5 21:19:23Click:1731

Oyster Point Pharmaceuticals has submitted a NASDAQ listing application to the US Securities and Exchange Commission, and plans to raise $ 85 million in an IPO. This is a biotechnology company dedicated to developing first-in-class therapies for dry ····

Read More

The first new medicine in 20 years! UCB's new epilepsy drug Nayzilam receives FDA approval

Author:adminTime:2019/11/28 9:52:07Click:1793

Belgian pharmaceutical company UCB recently announced that the US FDA has approved its latest antiepileptic drug (AED) Nayzilam (midazolam) nasal spray CIV. This is a benzodiazepine drug for nasal administration. It is suitable for the emergency trea····

Read More

Nasal spray for recurrent seizures! Neurelis Valtoco (Diazepam Nasal Spray) Enters Formal Review in

Author:adminTime:2019/11/28 9:47:27Click:1737

September 30, 2018 / BIOON /-Biopharma, a specialist pharmaceutical company based in San Diego, USA, focuses on licensing, developing, and commercializing drugs for epilepsy and other central nervous system (CNS) diseases. Recently, the company annou····

Read More

Newly discovered nasal spray may solve the problem of patients with sudden heart disease

Author:adminTime:2019/11/28 9:32:13Click:1714

Researchers report that experimental nasal sprays can help treat common rapid heart rate disorders. A spray called Etripamil was tested in paroxysmal supraventricular tachycardia (PSVT) patients. PSVT affects approximately 500,000 Americans and resul····

Read More